G-protein gated Inwardly Rectifying K+ channel 1 (GIRK1) Genotyping
G-protein gated Inwardly Rectifying K+ channel 1 (GIRK1), encoded by the KCNJ3 gene, is part of the inward rectifier potassium channel family (TC 1.A.2.1). The gene is located on chromosome 2 (2q24.1). GIRK1 channels are critical for neuronal excitability, cardiac rhythm regulation, and neurotransmitter signaling. They form heterotetrameric channels with other GIRK subunits (GIRK2, GIRK3, GIRK4) and are activated by G-protein coupled receptors (GPCRs).
A key variant, GRIK1 rs2832407, involves a C>A non-coding change. The C allele, predominant in European Americans, is associated with alcohol dependence susceptibility. Studies indicate that individuals with the homozygous C/C genotype show an improved response to topiramate therapy for alcohol dependence compared to C/A and A/A genotypes. The frequencies of the GRIK1 rs2832407 C allele are 63%, 40-50% and 11% in Caucasians, Asians and Africans respectively.
Topiramate is an FDA-approved anticonvulsant and migraine prophylactic. Off-label applications include treatment for essential tremors, smoking cessation, and alcohol dependence. Genetic screening for GRIK1 polymorphisms may help personalize topiramate therapy for individuals with alcohol addiction.
- Identification of genetic predisposition to alcohol dependence
- Personalized medicine approach for topiramate efficacy in alcohol use disorder
- Potential implications in cardiac arrhythmias and neurological disorders
| Genotype | Clinical Relevance |
|---|---|
| C/C (Homozygous) | Associated with better response to topiramate therapy for alcohol dependence |
| C/A (Heterozygous) | Intermediate response to topiramate therapy |
| A/A (Homozygous) | Lower likelihood of response to topiramate therapy |
rs2832407 C/C (Normal Genotype)
Whole Blood (EDTA).
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: 30 days
For Breast Tissue Analysis:
- Formalin-Fixed Paraffin-Embedded (FFPE) Tissue
- Int J Neuropsychopharmacol. 2014;17(10):1549-56. [PMID: 24786948]
- Addict Biol. 2016;21(2):450-9. [PMID: 25496338]
- Exp Clin Psychopharmacol. 2014;22(5):419-23. [PMID: 24978347]
- Am J Psychiatry. 2014;171(4):445-52. [PMID: 24525690]